A natural apolipoprotein A-I variant, apoA-I(L141R)(Pisa), interferes with the formation of α-high density lipoproteins (HDL) but not with the formation of prβ1-HDL and influences efflux of cholesterol into plasma

Journal of Lipid Research

Volumn 38, Issue 6, 1997, Pages 1242-1253

  Miccoli, Roberto ^a,b   Zhu, Yanhong ^a   Daum, Ulrike ^a   Wessling, Johannes ^a   Huang, Yadong ^a,c   Navalesi, Renzo ^b   Assmann, Gerd ^a   Von Eckardstein, Arnold ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

ApoA I variants; Familial hypoalphalipoproteinemia; HDL subclasses; Reverse cholesterol transport; Tangier disease

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ARTICLE; CHOLESTEROL TRANSPORT; ENZYME INHIBITION; ESTERIFICATION; FAMILIAL DISEASE; FIBROBLAST; HETEROZYGOTE; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA TYPE 1; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DENATURATION; TANGIER DISEASE;

ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL; COHORT STUDIES; ELECTROPHORESIS, AGAR GEL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; IMMUNE SERA; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; LIPOPROTEINS, HDL; MALE; REFERENCE VALUES; SHEEP; TANGIER DISEASE; TIME FACTORS;

EID: 0030966215     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Fielding, C., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
2. Brouilette, C. G., and G. M. Anantharamaiah. 1995. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta. 1256: 103-129.
3. Kawano, M., T. Miida, C. J. Fielding, and P. E. Fielding. 1993. Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry. 32: 5025-5028.
4. Czarnecka, H., and S. Yokoyama. 1996. Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange. J. Biol. Chem. 266: 2023-2028.
5. Czarnecka, H., and S. Yokoyama. 1995. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry. 34: 4385-4392.
6. von Eckardstein, A. 1996. Cholesterol efflux from macrophages and other cells. Curr. Opin. Lipidol. 7: 308-319.
7. von Eckardstein, A., Y. Huang, and G. Assmann. 1994. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr. Opin. Lipidol. 5: 404-416.
8. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
9. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
10. Li, Q., and S. Yokoyama. 1995. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J. Biol. Chem. 269: 26216-26223.
11. Barrans, A., B. Jaspard, R. Barbaras, H. Chap, B. Perret, and X. Collet. 1996. Pre-β HDL: structure and metabolism. Biochim Biophys. Acta. 1300: 73-83.
12. Mendez, A. J., J. F. Oram, and E. L. Bierman 1991. Protein kinase C as a mediator of high density lipoprotein dependent efflux of intracellular cholesterol. J. Biol. Chem. 266: 10104-10111.
13. 3 stimulates multiple signaling pathways in human skin fibroblasts: Arterioscler. Thromb. Vasc. Biol. 15: 1975-1986.
14. Holvoet, P., Z. Zhao, B. Vanloo, R. Vos, E. Deridder, A. Dhoest, J. Taveirne, E. Brouwers, E. Demarsin, Y. Engelborghs, M. Rosseneu, D. Collen, and R. Brasseur. 1995. Phospholipid binding and lecithin:cholesterol acyltransferase activation properties of apolipoprotein A-I variants. Biochemistry. 34: 13334-13342.
15. Schmidt, H. J., A. T. Remaley, J. A. Stonik, R. Ronan, A. Wellmann, F. Thomas, L. A. Zech, H. B. Brewer, Jr., and J. M. Hoeg. 1995. Carboxy-terminal domain truncation alters apolipoprotein A-I in vivo catabolism. J. Biol. Chem. 270: 5469-5475.
16. Banka, C. L., D. J. Bonnet, A. S. Black, R. S. Smith, and C. K. Curtiss. 1991. Localization of an apolipoprotein A-I epitope critical for activation of lecithin: cholesterol acyltransferase. J. Biol. Chem. 266: 23886-23892.
17. Mendez, A. J., G. M. Anantharamaiah, J. P. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94: 1698-1705.
18. Luchoomun, J., N. Theret, V. Clavey, P. Duchateau, M. Rosseneu, R. Brasseur. P. Denefle, J. C. Fruchart, and G. R. Castro. 1994. Structural domain of apolipoprotein A-I involved in its interaction with cells. Biochim. Biophys. Acta. 1212: 319-326.
19. 1-high density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry. 33: 6981-6985.
20. Sviridov, D., L. Pyle, and N. Fidge. 1996. Identification of a sequence in apolipoprotein A-I associated with the efflux of intracellular cholesterol to human species and apolipoprotein A-I-containing particles. Biochemistry. 35: 189-196.
21. Banka, C. L., A.S. Black, and L. K. Curtiss. 1994. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J. Biol. Chem. 269:10288-10297.
22. 165 → Arg). J. Biol. Chem. 268: 2616-2622.
23. Navalesi, R., R. Miccoli, L. Odoguardi, H. Funke, A. von Eckardstein, H. Wiebusch, and G. Assmann. 1995. Genetically determined absence of HDL-cholesterol and coronary atherosclerosis (letter). Lancet. 346: 708-709.
24. Pisa, causes high density lipoprotein deficiency, corneal opacifications, and coronary heart disease. Circulation. 94: 1622-1628.
25. Assmann, G., A. von Eckardstein, and H. B. Brewer, Jr. 1995. Familial high density lipoprotein deficiency: Tangier disease. In The Metabolic Basis of Inherited Disease. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill Book Co., New York. 2053-2072.
26. Assmann, G., E. Smootz, K. Adler, A. Capurso, and K. Oette. 1977. The lipoprotein abnormality in Tangier disease. Quantitation of A apoproteins. J. Clin. Invest. 59: 565-575.
27. Gibbels, E., H. E. Schaefer, U. Runne, J. M. Schröder, W. F. Haupt, and G. Assmann. 1985. Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies. J. Neurol. 232: 283-290.
28. Roemling, R., A. von Eckardstein, H. Funke, C. Motti, G. Fragiacomo, G. Noseda, and G. Assmann. 1994. A non-sense mutation in the apolipoprotein A-I gene is associted with high density lipoprotein deficiency but not with coronary heart disease. Arterioscler. Thromb. 14: 1915-1922.
29. Sandkamp, M., B. Tambyrajah, H. Schriewer, and G. Assmann. 1988. Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method. J. Clin. Chem. Clin. Biochem. 26: 685-689.
30. Pritchard, P. H., R. McLeod, J. Frohlich, M. C. Park, B. J. Kudchodkar, and A. G. Lacko. 1988. Lecithin:cholesterol acyltransferase in familial HDL-deficiency. Biochim. Biophys. Acta. 958: 227-234.
31. von Eckardstein, A., H. Funke, A. Chirazi, C. Chen-Haudenschild, H. Schulte, R. Schönfeld, E. Köhler, S. Schwarz, A. Steinmetz, and G. Assmann. 1994. Gender-specific effects of the glutamine/histidine polymorphism in apolipoprotein A-IV on high density lipoprotein metabolism. Arterioscler. Thromb. 14: 1114-1120.
32. Dobiasova, M. 1983. Lecithin: cholesterol acyltransferase and the regulation of endogenous cholesterol transport. Adv. Lipid Res. 20: 107-194.
33. Huang, Y., A. von Eckardstein, and G. Assmann. 1993. Cell-derived unesterified cholesterol recycles between low density lipoproteins and different high density lipoproteins for its effective esterification: Arterioscler. Thromb. 13: 445-458.
34. Huang, Y., A. von Eckardstein, S. Wu, and G. Assmann. 1995. Effects of the apolipoprotein E-polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J. Clin. Invest. 96: 2693-2701.
35. von Eckardstein, A., Y. Huang, S. Wu, G. Noseda, and G. Assmann. 1995. Reverse cholesterol transport in plasma of patients with different forms of familial high density lipoprotein deficiency. Arterioscler. Thromb. Vasc. Biol. 15: 690-701.
36. Menzel, H. J., E. Boerwinkle, S. Schrangl Will, and G. Utermann. 1988. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum. Genet. 79: 368-372.
37. 1-HDL conversion in Tangier disease. Arterioscler. Thromb. Vasc. Biol. 15: 1746-1754.
38. Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. J. Lipid Res. 38: 121-131.
39. Jonas, A., A. von Eckardstein, K. Kezdy, A. Steinmetz, and G. Assmann. 1991. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. J. Lipid Res. 32: 98-109.
40. Jonas, A., A. von Eckardstein, L. Churgay, W. W. Mantullin, and G. Assmann. 1993. Structural and functional properties of genetic and chemical variants of apolipoprotein A-I. Biochim. Biophys. Acta. 1166: 202-210.
41. Bergeron, J., P. G. Frank, D. Scales, Q. H. Meng, G. Castro, and Y. L. Marcel. 1995. Apolipoprotein A-I conformation in reconstituted discoidal lipoproteins varying in phospholipid and cholesterol content. J. Biol. Chem. 270: 7429-7438.
42. Sparks, D. L., W. S. Davidson, S. Lund-Katz, and M. C. Phillips. 1993. Effect of cholesterol on the charge and structure of apolipoprotein A-I in high density lipoprotein particles. J. Biol. Chem. 268: 23250-23257.
43. Davidson, W. S., D. L. Sparks, S. Lund-Katz, and M. C. Philips. 1994. The molecular basis for the difference of charge between prepβ and α-migrating high density lipoproteins. J. Biol. Chem. 269: 8959-8965.
44. Jonas, A. 1991. Lecithin: cholesterol acyltransferase in the metabolism of high density lipoproteins. Biochim. Biophys. Acta. 1084: 205-225.
45. Funke, H., A. von Eckardstein, P. H. Pritchard, M. Karas, J. J. Albers, and G. Assmann. 1991. A frameshift mutation in the human apolipoprotein A-I gene causes HDL deficiency, partial LCAT deficiency and corneal opacities; a disorder which is distinct from fish-eye disease. J. Clin. Invest. 87: 371-376.
46. Huang, Y., A. von Eckardstein, S. Wu, N. Maeda, and G. Assmann. 1994. A solely apolipoprotein E containing plasma lipoprotein with electrophoretic gamma-mobility takes up cellular cholesterol. Proc. Natl. Acad. Sci. USA. 91: 1834-1838.
47. von Eckardstein, A., Y. Huang, S. Wu, A. SaadatSarmadi, S. Schwarz, A. Steinmetz, and G. Assmann. 1995. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma. Arterioscler. Vasc. Biol. 15: 1755-1763.